Research feed
Recently added diabetes research, organized by intervention and outcome.
Sorted by when Dediabetes added each study.
This Phase III trial compared Liraglutide Biosimilar with reference Liraglutide, finding both effective in reducing body weight and improving glycemic control.
This study compared Long Biliopancreatic Limb Roux-en-Y Gastric Bypass (BPL-RYGB) to Long Alimentary Limb Roux-en-Y Gastric Bypass (AL-RYGB) in adults with obesity and Type 2 diabetes, finding a greater decrease in HbA1c with BPL-RYGB.
This study evaluated the efficacy of once-daily oral semaglutide 25 mg in adults with obesity and type 2 diabetes, finding significant weight reduction compared to placebo.
This study evaluated the effectiveness of a very low-calorie diet (VLCD) in newly diagnosed type 2 diabetes patients, finding significant improvements in insulin resistance and other metabolic markers.
The REPAIR trial investigated the effects of a plant-based lifestyle intervention on diabetes remission and weight loss. Results showed no significant differences compared to standard care.
This study evaluated the impact of a preconception lifestyle intervention on neonatal outcomes, finding no significant differences between intervention and control groups.
This study investigated the effects of semaglutide on weight loss in adults with metabolic dysfunction-associated steatotic liver disease. Semaglutide led to a significant weight reduction compared to placebo.
This study investigated the effects of structured exercise programs on glucose metabolism and weight loss in participants after Roux-en-Y gastric bypass, finding significant weight and fat mass reductions.
This pilot study investigated the effects of time-restricted eating on individuals with type 2 diabetes, revealing significant improvements in 1,5-Anhydroglucitol levels and hypoglycemia symptom recognition.
This study explored a time-restricted eating intervention for women with overweight/obesity and HIV in South Africa, finding positive outcomes in energy, appetite control, and weight loss.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
